nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C19—coronary artery disease	0.207	1	CbGaD
Carbinoxamine—CYP2C8—Fenofibrate—coronary artery disease	0.0278	0.0472	CbGbCtD
Carbinoxamine—CYP2B6—Clopidogrel—coronary artery disease	0.0254	0.0432	CbGbCtD
Carbinoxamine—CYP2C8—Gemfibrozil—coronary artery disease	0.0222	0.0377	CbGbCtD
Carbinoxamine—CYP2C9—Fenofibrate—coronary artery disease	0.0194	0.0329	CbGbCtD
Carbinoxamine—CYP2C8—Clopidogrel—coronary artery disease	0.0193	0.0327	CbGbCtD
Carbinoxamine—CYP2C19—Gemfibrozil—coronary artery disease	0.0186	0.0316	CbGbCtD
Carbinoxamine—CYP2C8—Pitavastatin—coronary artery disease	0.0168	0.0286	CbGbCtD
Carbinoxamine—CYP2C19—Clopidogrel—coronary artery disease	0.0162	0.0274	CbGbCtD
Carbinoxamine—CYP2C9—Gemfibrozil—coronary artery disease	0.0155	0.0263	CbGbCtD
Carbinoxamine—CYP2B6—Simvastatin—coronary artery disease	0.0152	0.0259	CbGbCtD
Carbinoxamine—CYP2C19—Telmisartan—coronary artery disease	0.0141	0.024	CbGbCtD
Carbinoxamine—CYP2B6—Atorvastatin—coronary artery disease	0.0136	0.023	CbGbCtD
Carbinoxamine—CYP2C9—Clopidogrel—coronary artery disease	0.0134	0.0228	CbGbCtD
Carbinoxamine—CYP3A4—Ticagrelor—coronary artery disease	0.0126	0.0215	CbGbCtD
Carbinoxamine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0121	0.0205	CbGbCtD
Carbinoxamine—CYP2C9—Pitavastatin—coronary artery disease	0.0117	0.0199	CbGbCtD
Carbinoxamine—CYP2C8—Simvastatin—coronary artery disease	0.0115	0.0196	CbGbCtD
Carbinoxamine—CYP2C9—Valsartan—coronary artery disease	0.0114	0.0194	CbGbCtD
Carbinoxamine—CYP2C19—Timolol—coronary artery disease	0.0114	0.0193	CbGbCtD
Carbinoxamine—CYP2C8—Lovastatin—coronary artery disease	0.0113	0.0192	CbGbCtD
Carbinoxamine—CYP2C8—Pravastatin—coronary artery disease	0.0113	0.0192	CbGbCtD
Carbinoxamine—CYP3A4—Fenofibrate—coronary artery disease	0.0113	0.0191	CbGbCtD
Carbinoxamine—CYP2C19—Rosuvastatin—coronary artery disease	0.0104	0.0177	CbGbCtD
Carbinoxamine—CYP2C8—Atorvastatin—coronary artery disease	0.0103	0.0175	CbGbCtD
Carbinoxamine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0101	0.0172	CbGbCtD
Carbinoxamine—CYP2C19—Simvastatin—coronary artery disease	0.00968	0.0164	CbGbCtD
Carbinoxamine—CYP2C19—Lovastatin—coronary artery disease	0.00948	0.0161	CbGbCtD
Carbinoxamine—CYP2C8—Losartan—coronary artery disease	0.00941	0.016	CbGbCtD
Carbinoxamine—CYP2D6—Niacin—coronary artery disease	0.00931	0.0158	CbGbCtD
Carbinoxamine—CYP3A4—Gemfibrozil—coronary artery disease	0.00901	0.0153	CbGbCtD
Carbinoxamine—CYP2C9—Rosuvastatin—coronary artery disease	0.00866	0.0147	CbGbCtD
Carbinoxamine—CYP2D6—Timolol—coronary artery disease	0.00866	0.0147	CbGbCtD
Carbinoxamine—CYP2C19—Atorvastatin—coronary artery disease	0.00863	0.0146	CbGbCtD
Carbinoxamine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00844	0.0143	CbGbCtD
Carbinoxamine—CYP2C9—Simvastatin—coronary artery disease	0.00805	0.0137	CbGbCtD
Carbinoxamine—CYP2C19—Losartan—coronary artery disease	0.00789	0.0134	CbGbCtD
Carbinoxamine—CYP2C9—Lovastatin—coronary artery disease	0.00788	0.0134	CbGbCtD
Carbinoxamine—CYP2C9—Pravastatin—coronary artery disease	0.00788	0.0134	CbGbCtD
Carbinoxamine—CYP3A4—Clopidogrel—coronary artery disease	0.00781	0.0133	CbGbCtD
Carbinoxamine—CYP2D6—Captopril—coronary artery disease	0.00762	0.0129	CbGbCtD
Carbinoxamine—CYP2D6—Simvastatin—coronary artery disease	0.00736	0.0125	CbGbCtD
Carbinoxamine—CYP3A4—Eplerenone—coronary artery disease	0.00726	0.0123	CbGbCtD
Carbinoxamine—CYP2D6—Pravastatin—coronary artery disease	0.0072	0.0122	CbGbCtD
Carbinoxamine—CYP2D6—Lovastatin—coronary artery disease	0.0072	0.0122	CbGbCtD
Carbinoxamine—CYP2C9—Atorvastatin—coronary artery disease	0.00717	0.0122	CbGbCtD
Carbinoxamine—CYP2C9—Losartan—coronary artery disease	0.00656	0.0111	CbGbCtD
Carbinoxamine—CYP2D6—Atorvastatin—coronary artery disease	0.00656	0.0111	CbGbCtD
Carbinoxamine—CYP3A4—Enalapril—coronary artery disease	0.00647	0.011	CbGbCtD
Carbinoxamine—CYP3A4—Rosuvastatin—coronary artery disease	0.00503	0.00854	CbGbCtD
Carbinoxamine—CYP3A4—Ezetimibe—coronary artery disease	0.00503	0.00854	CbGbCtD
Carbinoxamine—CYP3A4—Simvastatin—coronary artery disease	0.00468	0.00794	CbGbCtD
Carbinoxamine—CYP3A4—Lovastatin—coronary artery disease	0.00458	0.00777	CbGbCtD
Carbinoxamine—CYP3A4—Pravastatin—coronary artery disease	0.00458	0.00777	CbGbCtD
Carbinoxamine—CYP3A4—Atorvastatin—coronary artery disease	0.00417	0.00708	CbGbCtD
Carbinoxamine—CYP3A4—Losartan—coronary artery disease	0.00382	0.00647	CbGbCtD
Carbinoxamine—Clomipramine—HRH2—coronary artery disease	0.000366	0.334	CrCbGaD
Carbinoxamine—Feeling abnormal—Olmesartan—coronary artery disease	0.000163	0.00112	CcSEcCtD
Carbinoxamine—Paraesthesia—Telmisartan—coronary artery disease	0.000163	0.00112	CcSEcCtD
Carbinoxamine—Constipation—Pravastatin—coronary artery disease	0.000163	0.00112	CcSEcCtD
Carbinoxamine—Dyspepsia—Trandolapril—coronary artery disease	0.000163	0.00112	CcSEcCtD
Carbinoxamine—Asthenia—Clopidogrel—coronary artery disease	0.000163	0.00112	CcSEcCtD
Carbinoxamine—Confusional state—Losartan—coronary artery disease	0.000162	0.00112	CcSEcCtD
Carbinoxamine—Tension—Timolol—coronary artery disease	0.000162	0.00112	CcSEcCtD
Carbinoxamine—Dyspepsia—Enalapril—coronary artery disease	0.000162	0.00112	CcSEcCtD
Carbinoxamine—Asthenia—Lovastatin—coronary artery disease	0.000162	0.00111	CcSEcCtD
Carbinoxamine—Somnolence—Telmisartan—coronary artery disease	0.000161	0.00111	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Furosemide—coronary artery disease	0.000161	0.00111	CcSEcCtD
Carbinoxamine—Decreased appetite—Trandolapril—coronary artery disease	0.000161	0.00111	CcSEcCtD
Carbinoxamine—Nervousness—Timolol—coronary artery disease	0.00016	0.00111	CcSEcCtD
Carbinoxamine—Hypotension—Perindopril—coronary artery disease	0.00016	0.00111	CcSEcCtD
Carbinoxamine—Decreased appetite—Enalapril—coronary artery disease	0.00016	0.0011	CcSEcCtD
Carbinoxamine—Dyspepsia—Telmisartan—coronary artery disease	0.00016	0.0011	CcSEcCtD
Carbinoxamine—Insomnia—Captopril—coronary artery disease	0.00016	0.0011	CcSEcCtD
Carbinoxamine—Fatigue—Trandolapril—coronary artery disease	0.000159	0.0011	CcSEcCtD
Carbinoxamine—Anorexia—Furosemide—coronary artery disease	0.000159	0.0011	CcSEcCtD
Carbinoxamine—Fatigue—Enalapril—coronary artery disease	0.000159	0.00109	CcSEcCtD
Carbinoxamine—Paraesthesia—Captopril—coronary artery disease	0.000159	0.00109	CcSEcCtD
Carbinoxamine—Asthenia—Ezetimibe—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Tremor—Ramipril—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Constipation—Trandolapril—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Urticaria—Valsartan—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Chills—Lisinopril—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Decreased appetite—Telmisartan—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Nausea—Rosuvastatin—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Diarrhoea—Fenofibrate—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Losartan—coronary artery disease	0.000158	0.00109	CcSEcCtD
Carbinoxamine—Constipation—Enalapril—coronary artery disease	0.000157	0.00109	CcSEcCtD
Carbinoxamine—Urticaria—Olmesartan—coronary artery disease	0.000157	0.00108	CcSEcCtD
Carbinoxamine—Somnolence—Captopril—coronary artery disease	0.000157	0.00108	CcSEcCtD
Carbinoxamine—Tachycardia—Losartan—coronary artery disease	0.000157	0.00108	CcSEcCtD
Carbinoxamine—Feeling abnormal—Pravastatin—coronary artery disease	0.000157	0.00108	CcSEcCtD
Carbinoxamine—Fatigue—Telmisartan—coronary artery disease	0.000157	0.00108	CcSEcCtD
Carbinoxamine—Hypotension—Furosemide—coronary artery disease	0.000156	0.00107	CcSEcCtD
Carbinoxamine—Vision blurred—Timolol—coronary artery disease	0.000156	0.00107	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Losartan—coronary artery disease	0.000156	0.00107	CcSEcCtD
Carbinoxamine—Dyspepsia—Captopril—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Constipation—Telmisartan—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Agitation—Ramipril—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Insomnia—Perindopril—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Diarrhoea—Clopidogrel—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Asthenia—Eplerenone—coronary artery disease	0.000155	0.00107	CcSEcCtD
Carbinoxamine—Diarrhoea—Lovastatin—coronary artery disease	0.000154	0.00106	CcSEcCtD
Carbinoxamine—Paraesthesia—Perindopril—coronary artery disease	0.000154	0.00106	CcSEcCtD
Carbinoxamine—Urticaria—Niacin—coronary artery disease	0.000154	0.00106	CcSEcCtD
Carbinoxamine—Decreased appetite—Captopril—coronary artery disease	0.000154	0.00106	CcSEcCtD
Carbinoxamine—Anorexia—Losartan—coronary artery disease	0.000153	0.00106	CcSEcCtD
Carbinoxamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000153	0.00106	CcSEcCtD
Carbinoxamine—Dizziness—Fenofibrate—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Somnolence—Perindopril—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Feeling abnormal—Trandolapril—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Fatigue—Captopril—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Clomipramine—GSTP1—coronary artery disease	0.000152	0.139	CrCbGaD
Carbinoxamine—Vertigo—Ramipril—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Feeling abnormal—Enalapril—coronary artery disease	0.000152	0.00105	CcSEcCtD
Carbinoxamine—Urticaria—Pravastatin—coronary artery disease	0.000151	0.00104	CcSEcCtD
Carbinoxamine—Asthenia—Simvastatin—coronary artery disease	0.000151	0.00104	CcSEcCtD
Carbinoxamine—Diarrhoea—Ezetimibe—coronary artery disease	0.000151	0.00104	CcSEcCtD
Carbinoxamine—Constipation—Captopril—coronary artery disease	0.000151	0.00104	CcSEcCtD
Carbinoxamine—Dyspepsia—Perindopril—coronary artery disease	0.000151	0.00104	CcSEcCtD
Carbinoxamine—Tension—Lisinopril—coronary artery disease	0.00015	0.00104	CcSEcCtD
Carbinoxamine—Hypotension—Losartan—coronary artery disease	0.00015	0.00104	CcSEcCtD
Carbinoxamine—Dizziness—Clopidogrel—coronary artery disease	0.00015	0.00103	CcSEcCtD
Carbinoxamine—Paraesthesia—Furosemide—coronary artery disease	0.00015	0.00103	CcSEcCtD
Carbinoxamine—Feeling abnormal—Telmisartan—coronary artery disease	0.00015	0.00103	CcSEcCtD
Carbinoxamine—Palpitations—Ramipril—coronary artery disease	0.000149	0.00103	CcSEcCtD
Carbinoxamine—Decreased appetite—Perindopril—coronary artery disease	0.000149	0.00103	CcSEcCtD
Carbinoxamine—Dizziness—Lovastatin—coronary artery disease	0.000149	0.00103	CcSEcCtD
Carbinoxamine—Nervousness—Lisinopril—coronary artery disease	0.000149	0.00103	CcSEcCtD
Carbinoxamine—Vertigo—Timolol—coronary artery disease	0.000148	0.00102	CcSEcCtD
Carbinoxamine—Somnolence—Furosemide—coronary artery disease	0.000148	0.00102	CcSEcCtD
Carbinoxamine—Diarrhoea—Eplerenone—coronary artery disease	0.000148	0.00102	CcSEcCtD
Carbinoxamine—Fatigue—Perindopril—coronary artery disease	0.000148	0.00102	CcSEcCtD
Carbinoxamine—Urticaria—Trandolapril—coronary artery disease	0.000147	0.00101	CcSEcCtD
Carbinoxamine—Constipation—Perindopril—coronary artery disease	0.000147	0.00101	CcSEcCtD
Carbinoxamine—Vomiting—Fenofibrate—coronary artery disease	0.000147	0.00101	CcSEcCtD
Carbinoxamine—Convulsion—Ramipril—coronary artery disease	0.000146	0.00101	CcSEcCtD
Carbinoxamine—Urticaria—Enalapril—coronary artery disease	0.000146	0.00101	CcSEcCtD
Carbinoxamine—Dizziness—Ezetimibe—coronary artery disease	0.000146	0.00101	CcSEcCtD
Carbinoxamine—Palpitations—Timolol—coronary artery disease	0.000146	0.00101	CcSEcCtD
Carbinoxamine—Feeling abnormal—Captopril—coronary artery disease	0.000146	0.001	CcSEcCtD
Carbinoxamine—Insomnia—Losartan—coronary artery disease	0.000145	0.001	CcSEcCtD
Carbinoxamine—Decreased appetite—Furosemide—coronary artery disease	0.000145	0.000999	CcSEcCtD
Carbinoxamine—Headache—Fenofibrate—coronary artery disease	0.000144	0.000996	CcSEcCtD
Carbinoxamine—Vision blurred—Lisinopril—coronary artery disease	0.000144	0.000996	CcSEcCtD
Carbinoxamine—Paraesthesia—Losartan—coronary artery disease	0.000144	0.000996	CcSEcCtD
Carbinoxamine—Urticaria—Telmisartan—coronary artery disease	0.000144	0.000995	CcSEcCtD
Carbinoxamine—Vomiting—Clopidogrel—coronary artery disease	0.000144	0.000994	CcSEcCtD
Carbinoxamine—Diarrhoea—Simvastatin—coronary artery disease	0.000144	0.000994	CcSEcCtD
Carbinoxamine—Fatigue—Furosemide—coronary artery disease	0.000144	0.000991	CcSEcCtD
Carbinoxamine—Tremor—Lisinopril—coronary artery disease	0.000144	0.00099	CcSEcCtD
Carbinoxamine—Vomiting—Lovastatin—coronary artery disease	0.000143	0.000987	CcSEcCtD
Carbinoxamine—Somnolence—Losartan—coronary artery disease	0.000143	0.000986	CcSEcCtD
Carbinoxamine—Dizziness—Eplerenone—coronary artery disease	0.000143	0.000986	CcSEcCtD
Carbinoxamine—Asthenia—Valsartan—coronary artery disease	0.000143	0.000984	CcSEcCtD
Carbinoxamine—Constipation—Furosemide—coronary artery disease	0.000143	0.000983	CcSEcCtD
Carbinoxamine—Asthenia—Olmesartan—coronary artery disease	0.000142	0.000979	CcSEcCtD
Carbinoxamine—Headache—Clopidogrel—coronary artery disease	0.000142	0.000979	CcSEcCtD
Carbinoxamine—Dyspepsia—Losartan—coronary artery disease	0.000142	0.000976	CcSEcCtD
Carbinoxamine—Feeling abnormal—Perindopril—coronary artery disease	0.000141	0.000975	CcSEcCtD
Carbinoxamine—Headache—Lovastatin—coronary artery disease	0.000141	0.000973	CcSEcCtD
Carbinoxamine—Vomiting—Ezetimibe—coronary artery disease	0.00014	0.000968	CcSEcCtD
Carbinoxamine—Decreased appetite—Losartan—coronary artery disease	0.00014	0.000964	CcSEcCtD
Carbinoxamine—Dizziness—Simvastatin—coronary artery disease	0.000139	0.00096	CcSEcCtD
Carbinoxamine—Confusional state—Ramipril—coronary artery disease	0.000139	0.000959	CcSEcCtD
Carbinoxamine—Asthenia—Niacin—coronary artery disease	0.000139	0.000957	CcSEcCtD
Carbinoxamine—Fatigue—Losartan—coronary artery disease	0.000139	0.000956	CcSEcCtD
Carbinoxamine—Headache—Ezetimibe—coronary artery disease	0.000138	0.000954	CcSEcCtD
Carbinoxamine—Vertigo—Lisinopril—coronary artery disease	0.000138	0.00095	CcSEcCtD
Carbinoxamine—Constipation—Losartan—coronary artery disease	0.000138	0.000949	CcSEcCtD
Carbinoxamine—Vomiting—Eplerenone—coronary artery disease	0.000137	0.000948	CcSEcCtD
Carbinoxamine—Feeling abnormal—Furosemide—coronary artery disease	0.000137	0.000947	CcSEcCtD
Carbinoxamine—Nausea—Fenofibrate—coronary artery disease	0.000137	0.000945	CcSEcCtD
Carbinoxamine—Asthenia—Pravastatin—coronary artery disease	0.000137	0.000942	CcSEcCtD
Carbinoxamine—Urticaria—Perindopril—coronary artery disease	0.000136	0.00094	CcSEcCtD
Carbinoxamine—Diarrhoea—Valsartan—coronary artery disease	0.000136	0.000938	CcSEcCtD
Carbinoxamine—Confusional state—Timolol—coronary artery disease	0.000136	0.000938	CcSEcCtD
Carbinoxamine—Palpitations—Lisinopril—coronary artery disease	0.000135	0.000934	CcSEcCtD
Carbinoxamine—Diarrhoea—Olmesartan—coronary artery disease	0.000135	0.000934	CcSEcCtD
Carbinoxamine—Headache—Eplerenone—coronary artery disease	0.000135	0.000934	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Ramipril—coronary artery disease	0.000135	0.000931	CcSEcCtD
Carbinoxamine—Nausea—Clopidogrel—coronary artery disease	0.000135	0.000928	CcSEcCtD
Carbinoxamine—Tachycardia—Ramipril—coronary artery disease	0.000135	0.000928	CcSEcCtD
Carbinoxamine—Vomiting—Simvastatin—coronary artery disease	0.000134	0.000923	CcSEcCtD
Carbinoxamine—Nausea—Lovastatin—coronary artery disease	0.000134	0.000922	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Ramipril—coronary artery disease	0.000133	0.00092	CcSEcCtD
Carbinoxamine—Asthenia—Trandolapril—coronary artery disease	0.000133	0.000915	CcSEcCtD
Carbinoxamine—Feeling abnormal—Losartan—coronary artery disease	0.000133	0.000914	CcSEcCtD
Carbinoxamine—Urticaria—Furosemide—coronary artery disease	0.000132	0.000913	CcSEcCtD
Carbinoxamine—Diarrhoea—Niacin—coronary artery disease	0.000132	0.000912	CcSEcCtD
Carbinoxamine—Asthenia—Enalapril—coronary artery disease	0.000132	0.000911	CcSEcCtD
Carbinoxamine—Headache—Simvastatin—coronary artery disease	0.000132	0.00091	CcSEcCtD
Carbinoxamine—Dizziness—Valsartan—coronary artery disease	0.000132	0.000907	CcSEcCtD
Carbinoxamine—Anorexia—Ramipril—coronary artery disease	0.000131	0.000907	CcSEcCtD
Carbinoxamine—Nausea—Ezetimibe—coronary artery disease	0.000131	0.000905	CcSEcCtD
Carbinoxamine—Dizziness—Olmesartan—coronary artery disease	0.000131	0.000903	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Timolol—coronary artery disease	0.00013	0.000899	CcSEcCtD
Carbinoxamine—Asthenia—Telmisartan—coronary artery disease	0.00013	0.000899	CcSEcCtD
Carbinoxamine—Diarrhoea—Pravastatin—coronary artery disease	0.00013	0.000898	CcSEcCtD
Carbinoxamine—Hypotension—Ramipril—coronary artery disease	0.000129	0.000889	CcSEcCtD
Carbinoxamine—Anorexia—Timolol—coronary artery disease	0.000129	0.000886	CcSEcCtD
Carbinoxamine—Nausea—Eplerenone—coronary artery disease	0.000128	0.000885	CcSEcCtD
Carbinoxamine—Dizziness—Niacin—coronary artery disease	0.000128	0.000882	CcSEcCtD
Carbinoxamine—Urticaria—Losartan—coronary artery disease	0.000128	0.000881	CcSEcCtD
Carbinoxamine—Asthenia—Captopril—coronary artery disease	0.000127	0.000874	CcSEcCtD
Carbinoxamine—Diarrhoea—Trandolapril—coronary artery disease	0.000127	0.000872	CcSEcCtD
Carbinoxamine—Vomiting—Valsartan—coronary artery disease	0.000126	0.000872	CcSEcCtD
Carbinoxamine—Confusional state—Lisinopril—coronary artery disease	0.000126	0.00087	CcSEcCtD
Carbinoxamine—Diarrhoea—Enalapril—coronary artery disease	0.000126	0.000869	CcSEcCtD
Carbinoxamine—Hypotension—Timolol—coronary artery disease	0.000126	0.000869	CcSEcCtD
Carbinoxamine—Dizziness—Pravastatin—coronary artery disease	0.000126	0.000868	CcSEcCtD
Carbinoxamine—Vomiting—Olmesartan—coronary artery disease	0.000126	0.000868	CcSEcCtD
Carbinoxamine—Nausea—Simvastatin—coronary artery disease	0.000125	0.000863	CcSEcCtD
Carbinoxamine—Insomnia—Ramipril—coronary artery disease	0.000125	0.00086	CcSEcCtD
Carbinoxamine—Headache—Valsartan—coronary artery disease	0.000125	0.000859	CcSEcCtD
Carbinoxamine—Diarrhoea—Telmisartan—coronary artery disease	0.000124	0.000857	CcSEcCtD
Carbinoxamine—Headache—Olmesartan—coronary artery disease	0.000124	0.000855	CcSEcCtD
Carbinoxamine—Paraesthesia—Ramipril—coronary artery disease	0.000124	0.000854	CcSEcCtD
Carbinoxamine—Asthenia—Perindopril—coronary artery disease	0.000123	0.000849	CcSEcCtD
Carbinoxamine—Vomiting—Niacin—coronary artery disease	0.000123	0.000848	CcSEcCtD
Carbinoxamine—Somnolence—Ramipril—coronary artery disease	0.000123	0.000846	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Lisinopril—coronary artery disease	0.000122	0.000845	CcSEcCtD
Carbinoxamine—Dizziness—Trandolapril—coronary artery disease	0.000122	0.000843	CcSEcCtD
Carbinoxamine—Tachycardia—Lisinopril—coronary artery disease	0.000122	0.000842	CcSEcCtD
Carbinoxamine—Insomnia—Timolol—coronary artery disease	0.000122	0.000841	CcSEcCtD
Carbinoxamine—Dizziness—Enalapril—coronary artery disease	0.000122	0.00084	CcSEcCtD
Carbinoxamine—Dyspepsia—Ramipril—coronary artery disease	0.000121	0.000837	CcSEcCtD
Carbinoxamine—Headache—Niacin—coronary artery disease	0.000121	0.000835	CcSEcCtD
Carbinoxamine—Paraesthesia—Timolol—coronary artery disease	0.000121	0.000835	CcSEcCtD
Carbinoxamine—Vomiting—Pravastatin—coronary artery disease	0.000121	0.000835	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000121	0.000834	CcSEcCtD
Carbinoxamine—Diarrhoea—Captopril—coronary artery disease	0.000121	0.000833	CcSEcCtD
Carbinoxamine—Dizziness—Telmisartan—coronary artery disease	0.00012	0.000828	CcSEcCtD
Carbinoxamine—Decreased appetite—Ramipril—coronary artery disease	0.00012	0.000827	CcSEcCtD
Carbinoxamine—Somnolence—Timolol—coronary artery disease	0.00012	0.000827	CcSEcCtD
Carbinoxamine—Asthenia—Furosemide—coronary artery disease	0.00012	0.000825	CcSEcCtD
Carbinoxamine—Headache—Pravastatin—coronary artery disease	0.000119	0.000823	CcSEcCtD
Carbinoxamine—Anorexia—Lisinopril—coronary artery disease	0.000119	0.000822	CcSEcCtD
Carbinoxamine—Fatigue—Ramipril—coronary artery disease	0.000119	0.00082	CcSEcCtD
Carbinoxamine—Dyspepsia—Timolol—coronary artery disease	0.000119	0.000819	CcSEcCtD
Carbinoxamine—Nausea—Valsartan—coronary artery disease	0.000118	0.000815	CcSEcCtD
Carbinoxamine—Constipation—Ramipril—coronary artery disease	0.000118	0.000813	CcSEcCtD
Carbinoxamine—Nausea—Olmesartan—coronary artery disease	0.000118	0.000811	CcSEcCtD
Carbinoxamine—Vomiting—Trandolapril—coronary artery disease	0.000118	0.000811	CcSEcCtD
Carbinoxamine—Diarrhoea—Perindopril—coronary artery disease	0.000117	0.000809	CcSEcCtD
Carbinoxamine—Decreased appetite—Timolol—coronary artery disease	0.000117	0.000808	CcSEcCtD
Carbinoxamine—Vomiting—Enalapril—coronary artery disease	0.000117	0.000807	CcSEcCtD
Carbinoxamine—Hypotension—Lisinopril—coronary artery disease	0.000117	0.000806	CcSEcCtD
Carbinoxamine—Dizziness—Captopril—coronary artery disease	0.000117	0.000805	CcSEcCtD
Carbinoxamine—Fatigue—Timolol—coronary artery disease	0.000116	0.000802	CcSEcCtD
Carbinoxamine—Headache—Trandolapril—coronary artery disease	0.000116	0.000799	CcSEcCtD
Carbinoxamine—Vomiting—Telmisartan—coronary artery disease	0.000115	0.000796	CcSEcCtD
Carbinoxamine—Asthenia—Losartan—coronary artery disease	0.000115	0.000796	CcSEcCtD
Carbinoxamine—Headache—Enalapril—coronary artery disease	0.000115	0.000796	CcSEcCtD
Carbinoxamine—Nausea—Niacin—coronary artery disease	0.000115	0.000792	CcSEcCtD
Carbinoxamine—Diarrhoea—Furosemide—coronary artery disease	0.000114	0.000787	CcSEcCtD
Carbinoxamine—Headache—Telmisartan—coronary artery disease	0.000114	0.000785	CcSEcCtD
Carbinoxamine—Feeling abnormal—Ramipril—coronary artery disease	0.000114	0.000784	CcSEcCtD
Carbinoxamine—Dizziness—Perindopril—coronary artery disease	0.000113	0.000782	CcSEcCtD
Carbinoxamine—Insomnia—Lisinopril—coronary artery disease	0.000113	0.00078	CcSEcCtD
Carbinoxamine—Nausea—Pravastatin—coronary artery disease	0.000113	0.00078	CcSEcCtD
Carbinoxamine—Paraesthesia—Lisinopril—coronary artery disease	0.000112	0.000775	CcSEcCtD
Carbinoxamine—Vomiting—Captopril—coronary artery disease	0.000112	0.000774	CcSEcCtD
Carbinoxamine—Somnolence—Lisinopril—coronary artery disease	0.000111	0.000767	CcSEcCtD
Carbinoxamine—Feeling abnormal—Timolol—coronary artery disease	0.000111	0.000766	CcSEcCtD
Carbinoxamine—Headache—Captopril—coronary artery disease	0.000111	0.000763	CcSEcCtD
Carbinoxamine—Dizziness—Furosemide—coronary artery disease	0.00011	0.00076	CcSEcCtD
Carbinoxamine—Dyspepsia—Lisinopril—coronary artery disease	0.00011	0.000759	CcSEcCtD
Carbinoxamine—Diarrhoea—Losartan—coronary artery disease	0.00011	0.000759	CcSEcCtD
Carbinoxamine—Nausea—Trandolapril—coronary artery disease	0.00011	0.000757	CcSEcCtD
Carbinoxamine—Urticaria—Ramipril—coronary artery disease	0.00011	0.000756	CcSEcCtD
Carbinoxamine—Nausea—Enalapril—coronary artery disease	0.000109	0.000754	CcSEcCtD
Carbinoxamine—Vomiting—Perindopril—coronary artery disease	0.000109	0.000752	CcSEcCtD
Carbinoxamine—Decreased appetite—Lisinopril—coronary artery disease	0.000109	0.00075	CcSEcCtD
Carbinoxamine—Nausea—Telmisartan—coronary artery disease	0.000108	0.000744	CcSEcCtD
Carbinoxamine—Fatigue—Lisinopril—coronary artery disease	0.000108	0.000744	CcSEcCtD
Carbinoxamine—Headache—Perindopril—coronary artery disease	0.000107	0.000741	CcSEcCtD
Carbinoxamine—Urticaria—Timolol—coronary artery disease	0.000107	0.000739	CcSEcCtD
Carbinoxamine—Constipation—Lisinopril—coronary artery disease	0.000107	0.000738	CcSEcCtD
Carbinoxamine—Dizziness—Losartan—coronary artery disease	0.000106	0.000734	CcSEcCtD
Carbinoxamine—Vomiting—Furosemide—coronary artery disease	0.000106	0.000731	CcSEcCtD
Carbinoxamine—Nausea—Captopril—coronary artery disease	0.000105	0.000724	CcSEcCtD
Carbinoxamine—Brompheniramine—CYP2C19—coronary artery disease	0.000105	0.0956	CrCbGaD
Carbinoxamine—Headache—Furosemide—coronary artery disease	0.000104	0.00072	CcSEcCtD
Carbinoxamine—Feeling abnormal—Lisinopril—coronary artery disease	0.000103	0.000711	CcSEcCtD
Carbinoxamine—Vomiting—Losartan—coronary artery disease	0.000102	0.000705	CcSEcCtD
Carbinoxamine—Nausea—Perindopril—coronary artery disease	0.000102	0.000702	CcSEcCtD
Carbinoxamine—Headache—Losartan—coronary artery disease	0.000101	0.000695	CcSEcCtD
Carbinoxamine—Urticaria—Lisinopril—coronary artery disease	9.94e-05	0.000685	CcSEcCtD
Carbinoxamine—Nausea—Furosemide—coronary artery disease	9.9e-05	0.000683	CcSEcCtD
Carbinoxamine—Asthenia—Ramipril—coronary artery disease	9.9e-05	0.000682	CcSEcCtD
Carbinoxamine—Asthenia—Timolol—coronary artery disease	9.67e-05	0.000667	CcSEcCtD
Carbinoxamine—Nausea—Losartan—coronary artery disease	9.56e-05	0.000659	CcSEcCtD
Carbinoxamine—Diarrhoea—Ramipril—coronary artery disease	9.44e-05	0.000651	CcSEcCtD
Carbinoxamine—Diarrhoea—Timolol—coronary artery disease	9.23e-05	0.000636	CcSEcCtD
Carbinoxamine—Dizziness—Ramipril—coronary artery disease	9.12e-05	0.000629	CcSEcCtD
Carbinoxamine—Asthenia—Lisinopril—coronary artery disease	8.98e-05	0.000619	CcSEcCtD
Carbinoxamine—Dizziness—Timolol—coronary artery disease	8.92e-05	0.000615	CcSEcCtD
Carbinoxamine—Vomiting—Ramipril—coronary artery disease	8.77e-05	0.000605	CcSEcCtD
Carbinoxamine—Headache—Ramipril—coronary artery disease	8.64e-05	0.000596	CcSEcCtD
Carbinoxamine—Vomiting—Timolol—coronary artery disease	8.57e-05	0.000591	CcSEcCtD
Carbinoxamine—Diarrhoea—Lisinopril—coronary artery disease	8.56e-05	0.00059	CcSEcCtD
Carbinoxamine—Chlorpromazine—HTR7—coronary artery disease	8.55e-05	0.078	CrCbGaD
Carbinoxamine—Headache—Timolol—coronary artery disease	8.45e-05	0.000583	CcSEcCtD
Carbinoxamine—Dizziness—Lisinopril—coronary artery disease	8.27e-05	0.00057	CcSEcCtD
Carbinoxamine—Nausea—Ramipril—coronary artery disease	8.19e-05	0.000565	CcSEcCtD
Carbinoxamine—Nausea—Timolol—coronary artery disease	8.01e-05	0.000552	CcSEcCtD
Carbinoxamine—Vomiting—Lisinopril—coronary artery disease	7.95e-05	0.000548	CcSEcCtD
Carbinoxamine—Headache—Lisinopril—coronary artery disease	7.84e-05	0.00054	CcSEcCtD
Carbinoxamine—Clomipramine—CYP2C19—coronary artery disease	7.73e-05	0.0705	CrCbGaD
Carbinoxamine—Nausea—Lisinopril—coronary artery disease	7.43e-05	0.000512	CcSEcCtD
Carbinoxamine—Diphenhydramine—CYP2C19—coronary artery disease	6.98e-05	0.0637	CrCbGaD
Carbinoxamine—Clomipramine—HTR2A—coronary artery disease	6.26e-05	0.0571	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2A—coronary artery disease	6.24e-05	0.0569	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2A—coronary artery disease	4.3e-05	0.0392	CrCbGaD
Carbinoxamine—Clomipramine—ALB—coronary artery disease	4.29e-05	0.0391	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—coronary artery disease	2.94e-05	0.0268	CrCbGaD
Carbinoxamine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	4.95e-06	8.66e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EDN1—coronary artery disease	4.94e-06	8.64e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CTGF—coronary artery disease	4.92e-06	8.59e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL5—coronary artery disease	4.9e-06	8.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—LPL—coronary artery disease	4.9e-06	8.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—coronary artery disease	4.89e-06	8.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CTGF—coronary artery disease	4.87e-06	8.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.87e-06	8.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GOT2—coronary artery disease	4.87e-06	8.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PLCB1—coronary artery disease	4.87e-06	8.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF1—coronary artery disease	4.83e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CSF2—coronary artery disease	4.83e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.83e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GOT2—coronary artery disease	4.83e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA2—coronary artery disease	4.82e-06	8.42e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX2—coronary artery disease	4.82e-06	8.42e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.82e-06	8.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—LPL—coronary artery disease	4.8e-06	8.39e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LPL—coronary artery disease	4.8e-06	8.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—coronary artery disease	4.78e-06	8.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.78e-06	8.35e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX4—coronary artery disease	4.76e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.76e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.76e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HK1—coronary artery disease	4.76e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	4.75e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	4.75e-06	8.31e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCA1—coronary artery disease	4.72e-06	8.25e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HADHA—coronary artery disease	4.7e-06	8.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—coronary artery disease	4.68e-06	8.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CD36—coronary artery disease	4.66e-06	8.14e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.65e-06	8.12e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	4.63e-06	8.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTP1—coronary artery disease	4.6e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPP2CA—coronary artery disease	4.6e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPA—coronary artery disease	4.59e-06	8.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GOT1—coronary artery disease	4.57e-06	7.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GGT1—coronary artery disease	4.57e-06	7.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CD36—coronary artery disease	4.56e-06	7.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	4.56e-06	7.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—coronary artery disease	4.54e-06	7.93e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	4.52e-06	7.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPP2CA—coronary artery disease	4.5e-06	7.87e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	4.5e-06	7.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.48e-06	7.83e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAT—coronary artery disease	4.48e-06	7.82e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.45e-06	7.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.44e-06	7.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	4.42e-06	7.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—coronary artery disease	4.41e-06	7.71e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA5—coronary artery disease	4.41e-06	7.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.36e-06	7.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOB—coronary artery disease	4.35e-06	7.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.34e-06	7.59e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	4.32e-06	7.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—coronary artery disease	4.32e-06	7.55e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—P4HB—coronary artery disease	4.32e-06	7.55e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—C3—coronary artery disease	4.32e-06	7.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.3e-06	7.52e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.24e-06	7.41e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—coronary artery disease	4.23e-06	7.39e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GGT1—coronary artery disease	4.21e-06	7.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GOT1—coronary artery disease	4.21e-06	7.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AGT—coronary artery disease	4.19e-06	7.33e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GOT1—coronary artery disease	4.17e-06	7.29e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GGT1—coronary artery disease	4.17e-06	7.29e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LPL—coronary artery disease	4.15e-06	7.25e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	4.12e-06	7.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—coronary artery disease	4.11e-06	7.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AGT—coronary artery disease	4.11e-06	7.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.11e-06	7.18e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGT—coronary artery disease	4.1e-06	7.17e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.07e-06	7.11e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOA1—coronary artery disease	4.06e-06	7.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.05e-06	7.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—coronary artery disease	4.05e-06	7.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—coronary artery disease	4.02e-06	7.03e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—coronary artery disease	4.02e-06	7.02e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—coronary artery disease	4.02e-06	7.02e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—VCAN—coronary artery disease	4e-06	6.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAT—coronary artery disease	4e-06	6.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOA1—coronary artery disease	3.98e-06	6.95e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOA1—coronary artery disease	3.97e-06	6.94e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.97e-06	6.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD36—coronary artery disease	3.94e-06	6.89e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KDR—coronary artery disease	3.94e-06	6.88e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	3.91e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.89e-06	6.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOB—coronary artery disease	3.88e-06	6.78e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DCN—coronary artery disease	3.85e-06	6.73e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—coronary artery disease	3.84e-06	6.71e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—F2—coronary artery disease	3.79e-06	6.62e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FN1—coronary artery disease	3.79e-06	6.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.78e-06	6.6e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	3.78e-06	6.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.77e-06	6.6e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.75e-06	6.55e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	3.75e-06	6.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.74e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.74e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.74e-06	6.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.73e-06	6.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.71e-06	6.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LPL—coronary artery disease	3.7e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.69e-06	6.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAT—coronary artery disease	3.68e-06	6.42e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.65e-06	6.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.65e-06	6.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.65e-06	6.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.65e-06	6.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAT—coronary artery disease	3.64e-06	6.37e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.63e-06	6.34e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KIT—coronary artery disease	3.63e-06	6.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—coronary artery disease	3.61e-06	6.32e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.61e-06	6.3e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—coronary artery disease	3.58e-06	6.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOB—coronary artery disease	3.57e-06	6.24e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.56e-06	6.23e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.56e-06	6.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AGT—coronary artery disease	3.55e-06	6.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOB—coronary artery disease	3.54e-06	6.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—coronary artery disease	3.53e-06	6.17e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.52e-06	6.15e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CETP—coronary artery disease	3.52e-06	6.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD36—coronary artery disease	3.52e-06	6.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—coronary artery disease	3.51e-06	6.13e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.48e-06	6.09e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	3.48e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—coronary artery disease	3.48e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.48e-06	6.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.47e-06	6.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—coronary artery disease	3.46e-06	6.04e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—coronary artery disease	3.45e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CREB1—coronary artery disease	3.45e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.44e-06	6.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOA1—coronary artery disease	3.44e-06	6.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LPL—coronary artery disease	3.41e-06	5.95e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—coronary artery disease	3.38e-06	5.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LPL—coronary artery disease	3.38e-06	5.9e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6R—coronary artery disease	3.37e-06	5.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.34e-06	5.83e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—coronary artery disease	3.32e-06	5.81e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—coronary artery disease	3.32e-06	5.8e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	3.31e-06	5.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—coronary artery disease	3.3e-06	5.76e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.29e-06	5.75e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.29e-06	5.75e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.29e-06	5.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD36—coronary artery disease	3.24e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—coronary artery disease	3.22e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CTGF—coronary artery disease	3.21e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD36—coronary artery disease	3.21e-06	5.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.2e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.18e-06	5.57e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GOT2—coronary artery disease	3.18e-06	5.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.17e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AGT—coronary artery disease	3.17e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.16e-06	5.52e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	3.15e-06	5.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—coronary artery disease	3.15e-06	5.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—coronary artery disease	3.11e-06	5.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—coronary artery disease	3.08e-06	5.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOA1—coronary artery disease	3.07e-06	5.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.07e-06	5.36e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF2—coronary artery disease	3.05e-06	5.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.04e-06	5.31e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—coronary artery disease	3.03e-06	5.3e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—coronary artery disease	3.02e-06	5.27e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—coronary artery disease	3.01e-06	5.26e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—coronary artery disease	2.99e-06	5.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.94e-06	5.14e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.93e-06	5.12e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.93e-06	5.11e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AGT—coronary artery disease	2.91e-06	5.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AGT—coronary artery disease	2.89e-06	5.05e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.87e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—coronary artery disease	2.86e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.84e-06	4.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—coronary artery disease	2.83e-06	4.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOA1—coronary artery disease	2.82e-06	4.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—coronary artery disease	2.82e-06	4.92e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOA1—coronary artery disease	2.8e-06	4.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—coronary artery disease	2.76e-06	4.82e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.75e-06	4.8e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.75e-06	4.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—coronary artery disease	2.72e-06	4.76e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—coronary artery disease	2.7e-06	4.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.68e-06	4.68e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	2.67e-06	4.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—coronary artery disease	2.67e-06	4.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—coronary artery disease	2.61e-06	4.55e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	2.58e-06	4.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—coronary artery disease	2.56e-06	4.47e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—coronary artery disease	2.54e-06	4.44e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—coronary artery disease	2.49e-06	4.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.49e-06	4.35e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.47e-06	4.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.47e-06	4.31e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—coronary artery disease	2.45e-06	4.29e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.45e-06	4.28e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.44e-06	4.26e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—coronary artery disease	2.43e-06	4.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—coronary artery disease	2.43e-06	4.25e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—coronary artery disease	2.42e-06	4.22e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAT—coronary artery disease	2.4e-06	4.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.38e-06	4.17e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	2.34e-06	4.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOB—coronary artery disease	2.33e-06	4.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.33e-06	4.07e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.27e-06	3.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—coronary artery disease	2.24e-06	3.91e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPL—coronary artery disease	2.23e-06	3.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—coronary artery disease	2.22e-06	3.88e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.17e-06	3.8e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	2.17e-06	3.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.14e-06	3.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.13e-06	3.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—coronary artery disease	2.12e-06	3.71e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD36—coronary artery disease	2.12e-06	3.7e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.09e-06	3.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.01e-06	3.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.99e-06	3.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.96e-06	3.42e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.95e-06	3.41e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.94e-06	3.39e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AGT—coronary artery disease	1.91e-06	3.33e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—coronary artery disease	1.87e-06	3.26e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.85e-06	3.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.73e-06	3.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.7e-06	2.96e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.69e-06	2.96e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.63e-06	2.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—coronary artery disease	1.6e-06	2.8e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.5e-06	2.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.47e-06	2.56e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—coronary artery disease	1.46e-06	2.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—coronary artery disease	1.42e-06	2.47e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.4e-06	2.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—coronary artery disease	1.39e-06	2.42e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.38e-06	2.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.31e-06	2.29e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.28e-06	2.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.2e-06	2.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—coronary artery disease	1.2e-06	2.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.19e-06	2.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—coronary artery disease	1.07e-06	1.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—coronary artery disease	9.84e-07	1.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—coronary artery disease	9.75e-07	1.7e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.87e-07	1.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—coronary artery disease	6.43e-07	1.12e-05	CbGpPWpGaD
